Showing results (1-10 of 299) with videos related to
Sort By:
Pageof 30
Journal of Clinical Pathology|March 1, 1981
An unexpected fungal infection in a patient with leukaemiaB Jameson, R L Carter, J G Watson, et al.Transplantation|November 1, 1983
Infections after bone marrow transplantation using cyclosporineH E Kay, J G Watson, B Jameson, et al.Lancet (London, England)|October 31, 1981
Acute myeloid leukaemia: comparison of support required during initial induction of remission and marrow transplantation in first remissionJ G Watson, R L Powles, H M Clink, et al.Journal of Clinical Pathology|June 1, 1983
Problems of infection after bone marrow transplantationJ G WatsonExpert Opinion on Investigational Drugs|August 24, 2007
Early experience with novel immunomodulators for cancer treatmentZiad Thotathil, Michael B JamesonExpert Opinion on Drug Metabolism & Toxicology|August 30, 2011
Pharmacokinetic evaluation of vadimezan (ASA404, 5,6-dimethylxanthenone-4-acetic acid, DMXAA)Michael B Jameson, Michelle HeadExpert Opinion on Investigational Drugs|January 7, 2010
The development of the tumor vascular-disrupting agent ASA404 (vadimezan, DMXAA): current status and future opportunitiesMichelle Head, Michael B JamesonJournal of Primary Health Care|May 2, 2019
Skin lesions suspicious for melanoma: New Zealand excision margin guidelines in practiceTess Brian, Michael B JamesonInternal Medicine Journal|November 11, 2019
Testicular cancer: a 13-year retrospective review of ethnic disparities in the Waikato region, New ZealandPrashanth Hari Dass, Michael B JamesonJournal of Thoracic Disease|January 21, 2012
Comparative outcomes of squamous and non-squamous non-small cell lung cancer (NSCLC) patients in phase II studies of ASA404 (DMXAA) - retrospective analysis of pooled dataMark J McKeage, Michael B Jameson, Pageof 30